Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0GH1C
|
||||
| Former ID |
DIB003763
|
||||
| Drug Name |
CVT-1
|
||||
| Indication | Hypercholesterolemia [ICD10:E78] | Terminated | [1] | ||
| Company |
Gilead Palo Alto Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Bile-salt-activated lipase | Target Info | Modulator | [1] | |
| BioCyc Pathway | Triacylglycerol degradation | ||||
| WikiPathways | Lipid digestion, mobilization, and transport | ||||
| References | |||||
| REF 1 | Lack of effect of cholesterol esterase inhibitor CVT-1 on cholesterol absorption and LDL cholesterol in humans. Cardiovasc Drugs Ther. 1999 Sep;13(5):449-54. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.